Cargando…

METTL3-Mediated m(6)A Modification of lncRNA MALAT1 Facilitates Prostate Cancer Growth by Activation of PI3K/AKT Signaling

Accumulating data show that N6-methyladenosine (m(6)A) methyltransferase METTL3 and long noncoding RNA MALAT1 act pivotal roles in multiple malignancies including prostate cancer (PCa). However, the role and molecular mechanism underlying METTL3-mediated m(6)A modification of MALAT1 in PCa remain un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Yuanshen, Li, Wenfeng, Weng, YiMing, Hua, Bao, Gu, Xin, Lu, Chao, Xu, Bin, Xu, Huan, Wang, Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459491/ https://www.ncbi.nlm.nih.gov/pubmed/36073002 http://dx.doi.org/10.1177/09636897221122997

Ejemplares similares

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
por: Song, Zhengwei, et al.
Publicado: (2022)

lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway
por: Zhu, Kongxi, et al.
Publicado: (2019)

LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway
por: Dai, Qingqiang, et al.
Publicado: (2020)

Sasanquasaponin inhibited epithelial to mesenchymal transition in prostate cancer by regulating the PI3K/Akt/mTOR and Smad pathways
por: Li, Wenfeng, et al.
Publicado: (2022)

METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis
por: Li, Changshu, et al.
Publicado: (2023)

LncRNA AC020978 facilitates non–small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway
por: Xu, Fei, et al.
Publicado: (2021)

LncRNA MALAT1 promotes osteoarthritis by modulating miR-150-5p/AKT3 axis
por: Zhang, Ying, et al.
Publicado: (2019)

METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA
por: Meng, Liping, et al.
Publicado: (2022)

METTL3‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway
por: Cui, Shoubin
Publicado: (2022)

Regulatory Networks of LncRNA MALAT-1 in Cancer
por: Fu, Shijian, et al.
Publicado: (2020)

lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p
por: Zhao, Yuxin, et al.
Publicado: (2021)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

lncRNA MALAT1 Promotes EMT Process and Cisplatin Resistance of Oral Squamous Cell Carcinoma via PI3K/AKT/m-TOR Signal Pathway
por: Wang, Ran, et al.
Publicado: (2020)

LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications
por: Huang, Shiqing, et al.
Publicado: (2022)

LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K/AKT signaling pathway
por: Zhou, Feng-Juan, et al.
Publicado: (2022)

N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway
por: Tan, Lei, et al.
Publicado: (2021)

LncRNA expression profile during autophagy and Malat1 function in macrophages
por: Ma, Zhanbing, et al.
Publicado: (2019)

LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging
por: Zhang, Jun, et al.
Publicado: (2020)

Deciphering the map of METTL14‐mediated lncRNA m6A modification at the transcriptome‐wide level in breast cancer
por: Yi, Dandan, et al.
Publicado: (2022)

Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells
por: Hu, Yi, et al.
Publicado: (2023)

Natural antisense RNA promotes 3′ end processing and maturation of MALAT1 lncRNA
por: Zong, Xinying, et al.
Publicado: (2016)

LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer
por: Hao, Longhui, et al.
Publicado: (2023)

LncRNA MALAT1 negatively regulates MDSCs in patients with lung cancer
por: Zhou, Qinfeng, et al.
Publicado: (2018)

The LINK-A lncRNA interacts with PI(3,4,5)P(3) to hyperactivate AKT and confer resistance to AKT inhibitors
por: Lin, Aifu, et al.
Publicado: (2017)

LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
por: Cai, Li-Jun, et al.
Publicado: (2020)

LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment
por: Mao, Tsui-Lien, et al.
Publicado: (2021)

LncRNA MALAT1 Modulates TGF-β1-Induced EMT in Keratinocyte
por: Zhang, Liping, et al.
Publicado: (2021)

The role of LncRNA MALAT-1 and MiRNA-9 in Psoriasis
por: Elamir, Azza M., et al.
Publicado: (2021)

Functions and mechanisms of lncRNA MALAT1 in cancer chemotherapy resistance
por: Hou, Junhui, et al.
Publicado: (2023)

LncRNA MALAT1 knockdown inhibits the development of choroidal neovascularization
por: Zhang, Xiaoli, et al.
Publicado: (2023)

lncRNA Gm16410 Mediates PM(2).(5)-Induced Macrophage Activation via PI3K/AKT Pathway
por: Xu, Jingbin, et al.
Publicado: (2021)

LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA
por: Tang, Jianming, et al.
Publicado: (2018)

METTL3 Attenuates Inflammation in Fusarium solani–Induced Keratitis via the PI3K/AKT Signaling Pathway
por: Huang, Liwei, et al.
Publicado: (2022)

The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis
por: Xia, Hongwei, et al.
Publicado: (2016)

EPC‐derived exosomes promote osteoclastogenesis through LncRNA‐MALAT1
por: Cui, Yigong, et al.
Publicado: (2019)

The Role of the lncRNA MALAT1 in Neuroprotection against Hypoxic/Ischemic Injury
por: Wang, Liping, et al.
Publicado: (2022)

Role of lncRNA MALAT1 in UVA-induced corneal endothelial senescence
por: Qiao, Yujie, et al.
Publicado: (2023)

METTL3-induced lncRNA GBAP1 promotes hepatocellular carcinoma progression by activating BMP/SMAD pathway
por: Liu, Runkun, et al.
Publicado: (2023)

METTL3-Mediated LncRNA EN_42575 m6A Modification Alleviates CPB2 Toxin-Induced Damage in IPEC-J2 Cells
por: Yang, Jiaojiao, et al.
Publicado: (2023)

METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors
por: Iaiza, Alessia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mjt4cfg3125aq29eki320geg8l